Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories
Do not stop using this medicine without talking to your doctor
The company reported $8.55 in earnings per share (EPS), 156% above last year's results in this area and a full $1.58 above analyst expectations
Cloudy solution can mean degradation or contamination
By understanding these roadblocks, youll be better equipped to adjust your plan, break through plateaus, and get back on track
US$ 29.80
US$ 28.94
US$ 20.96
US$ 29.85
US$ 28.72
US$ 25.86
